Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) EBIT: 2020-2025

Historic EBIT for IDEAYA Biosciences (IDYA) over the last 4 years, with Sep 2025 value amounting to $108.5 million.

  • IDEAYA Biosciences' EBIT rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
  • IDEAYA Biosciences' EBIT amounted to $108.5 million in Q3 2025, which was up 175.24% from -$144.1 million recorded in Q4 2024.
  • IDEAYA Biosciences' EBIT's 5-year high stood at $108.5 million during Q3 2025, with a 5-year trough of -$144.1 million in Q4 2024.
  • In the last 3 years, IDEAYA Biosciences' EBIT had a median value of -$41.9 million in 2023 and averaged -$39.2 million.
  • As far as peak fluctuations go, IDEAYA Biosciences' EBIT slumped by 5,179.70% in 2023, and later spiked by 262.13% in 2025.
  • Quarterly analysis of 5 years shows IDEAYA Biosciences' EBIT stood at -$18.4 million in 2021, then crashed by 43.95% to -$26.4 million in 2022, then plummeted by 58.52% to -$41.9 million in 2023, then crashed by 243.87% to -$144.1 million in 2024, then surged by 262.13% to $108.5 million in 2025.
  • Its last three reported values are $108.5 million in Q3 2025, -$144.1 million for Q4 2024, and -$66.9 million during Q3 2024.